MIRA
INFORM REPORT
|
Report Date : |
24.08.2007 |
IDENTIFICATION DETAILS
|
Name : |
U-MED INDUSTRIAL INC |
|
|
|
|
Registered Office : |
Yamamoto Bldg, 3-39-9 Hongo Bunkyoku |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
30.04.2007 |
|
|
|
|
Date of Incorporation : |
Jan 1983 |
|
|
|
|
Legal Form : |
Limited Company (Kabushiki
Kaisha) |
|
|
|
|
Line of Business : |
Import, wholesale of medical
apparatus |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
Yen 3 millions |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
name
U-MED INDUSTRIAL INC
REGD NAME
U-Med Boeki KK
MAIN OFFICE
Yamamoto Bldg,
3-39-9 Hongo Bunkyoku
Tel : 03-3815-4853
Fax : 03-3815-4872
URL : http://www.adoscope.co.jp
E-Mail
address: info@adoscope.co.jp
ACTIVITIES
Import,
wholesale of medical apparatus
BRANCHES
Nil
OFFICERS
SOTOJI
UMEZAWA, PRES Akemi
Umezawa, dir
Ryosuke
Umezawa, dir Shimpei
Umezawa, dir
Yen
Amount: In million Yen, unless
otherwise stated
SUMMARY
FINANCES FAIR A/SALES Yen 163 M
PAYMENTS REGULAR CAPITAL Yen 10 M
TREND STEADY WORTH Yen
38 M
STARTED 1983 EMPLOYES 2
COMMENT
IMPORTER OF ADOSCOPE. FINANCIAL SITUATION CONSIDERED FAIR AND GOOD FOR ORDINARY BUSINESS ENGAGEMENTS.
MAX
CREDIT LIMIT: YEN 3 MILLION, 30 DAYS NORMAL TERMS. .
HIGHLIGHTS
The subject company was established by Sotoji Umezawa in order
to make most of his experience in the subject line of business. This is a trading firm specializing in import
and wholesale of medical apparatus; stethoscope centrally, as agent dealer for
American Diagnostic Corp,
FINANCIAL INFORMATION
Financials are only partially disclosed.
The sales volume for Apr/2007 fiscal term amounted to Yen 163 million, a 26% hike from Yen 129 million in the previous term. A large lot of orders received from medical institutions. The net profit was posted at Yen 4 million, compared with Yen 3 million a year ago.
For the current term ending Apr 2008 the net profit is projected at Yen 4 million, on a 7% rise in turnover, to Yen 175 million.
The financial situation is considered maintained FAIR and good for ORDINARY business engagements. Max credit limit is estimated at Yen 3 million, on 30 days normal terms.
REGISTRATION
Date
Registered: Jan 1983
Legal
Status: Limited Company
(Kabushiki Kaisha)
Authorized: 80,000 shares
Issued: 20,000 shares
Sum: Yen 10 million
Major shareholders (%): Sotoji
Umezawa (100)
Nothing
detrimental is known as to the commercial morality of executives.
OPERATION
Activities: Imports and wholesales stethoscope, blood-pressure gauge, injection devices, sterilizing apparatus, oxygen breathing apparatus, anesthesia, nasal speculum, aural speculum, exploring needle, dental mirror, tone depressor, other medical apparatus (--100%).
Clients:
[Hospitals, laboratories] Kobayashi Shoji, other
No. of
accounts: 300
Domestic
areas of activities: Centered in greater-Tokyo
Suppliers: [Mfrs, wholesalers] Imports from American Diagnostic
Corp (USA) as import agent, also from Europe,
Domestically
supplied from Wako, other.
Payment
record: Regular
Location: Business area in
Bank References
Resona
Bank (Hongo)
Relations:
Satisfactory
FINANCES
(In
Million Yen)
|
Terms Ending: |
|
30/04/2008 |
30/04/2007 |
30/04/2006 |
30/04/2005 |
|
|
Annual
Sales |
|
175 |
163 |
129 |
130 |
|
|
Recur.
Profit |
|
|
|
|
|
|
|
Net
Profit |
|
4 |
4 |
3 |
4 |
|
|
Total
Assets |
|
|
N/A |
N/A |
N/A |
|
|
Net
Worth |
|
|
38 |
34 |
31 |
|
|
Capital,
Paid-Up |
|
|
10 |
10 |
10 |
|
|
Div.P.Share(¥) |
|
|
0.00 |
0.00 |
0.00 |
|
|
<Analytical Data> |
(%) |
(%) |
(%) |
(%) |
||
|
S.Growth Rate |
7.36 |
26.36 |
-0.77 |
8.33 |
||
|
Current Ratio |
|
|
.. |
.. |
.. |
|
|
N.Worth Ratio |
|
.. |
.. |
.. |
||
|
N.Profit/Sales |
2.29 |
2.45 |
2.33 |
3.08 |
||
Note:
Financials are only partially disclosed.
Forecast
(or estimated) for the 30/04/2008 fiscal term.
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)